Gracell Biotechnologies (GRCL) Price-to-Earnings (P/E) Ratio
Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Gracell Biotechnologies's P/E ratios across different time periods:
- TTM: -29.21
- Annual: -2.81
- Quarterly: -6.52
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 1.24
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
Gracell Biotechnologies Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-29.21
P/B Ratio (Annual)
1.24
P/S Ratio (Annual)
0.00
Gracell Biotechnologies Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2022.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2022 | -2.81 | 1.24 | 0.00 |
| 2021 | -5.42 | 1.38 | 6894.82 |
| 2020 | -54.38 | 13.08 | 0.00 |
| 2019 | -26.15 | 13.53 | 0.00 |
| 2018 | -56.14 | 1432.24 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for GRCL.